Home Tags SH Department of Biomedicine University Hospital Basel

SH Department of Biomedicine University Hospital Basel Related Content

Department of Biomedicine

Pulmonary Cell Research

Prof. Dr. Michael Roth discusses pulmonary cell research and cell differentiation in chronic inflammatory lung diseases Chronic inflammatory lung diseases (asthma, COPD, fibrosis) are increasing worldwide. None of the diseases can be cured, only the symptoms can be controlled by anti-inflammatory and muscle relaxant drugs. The pathogenesis of chronic inflammatory...
Why can asthma still not be cured

Health research: Why can asthma still not be cured?

Michael Roth, Research Group Leader at the University Hospital Basel explains what asthma is, its health impact and charts research landscape in the field.
Asthma and COPD

Do we know the cause of asthma and COPD?

Michael Roth, Research Group Leader at the University Hospital Basel & University Basel share his expertise on asthma and COPD, the most prevalent chronic inflammatory diseases of the lung globally
Department of Biomedicine

Finding disease specific indicators for chronic inflammatory lung diseases

Prof Dr Michael Roth asks the question, Why do we fail to find disease specific indicators for chronic inflammatory lung diseases?
chronic inflammatory lung diseases

The need to improve the diagnosis of chronic inflammatory lung diseases

Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
chronic inflammatory lung diseases

Asthma: Understanding chronic inflammatory lung diseases

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

Do we know the cause of asthma and COPD

Prof Dr Michael Roth (PhD), Research Group Leader Pulmonary Cell Research at the University Hospital Basel in Switzerland explains the extent to which asthma and COPD (smoker’s lung) are the most prevalent chronic inflammatory diseases of the lung, globally
Pneumology & Pulmonary Cell Research university hospital basel

Where are the new asthma drugs?

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...
Innovative Therapies

Developing innovative therapies to treat asthma

Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...
Pneumology & Pulmonary Cell Research

Pneumology & Pulmonary Cell Research

Prof Dr Michael Roth (PhD) at University Hospital Basel looks at pneumology & pulmonary cell research, in this profile of the organisation's research

Pre-disposition to chronic inflammatory lung diseases

Michael Roth, Research Group Leader, Pulmonary Cell Research at University Hospital Basel & University Basel sheds light on inflammatory lung diseases

New concepts for the pathogenesis and asthma therapy

Prof Dr. Michael Roth, University Hospital Basel looks at how asthma therapy can reduce the effects of airway wall remodelling

Follow Open Access Government